Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
Surveillance for good? Facebook tracks disaster victims
06/08/2017. The initiative will use aggregated and anonymised Facebook user data to produce 3 different kinds of maps: where people are checking in as safe; where populations are before, during, and after a natural disaster; and where people are moving to in the hours after disaster strikes.
How to manage the migrant crisis
02/06/2016. A European problem demands a common, coherent EU policy. Let refugees in, but regulate the flow
Local aid agencies: still waiting for a bigger share of the funding cake
03/27/2017. Donors and UN agencies who agreed to provide at least one quarter of humanitarian aid funding “as directly as possible” to local NGOs are struggling to deliver on their pledge.
